Fire Incident halts production at Aurobindo Pharma subsidiary 

Aurobindo Pharma reports fire incident at Penicillin-G facility, operations suspended for 20-25 days, no injuries, minimal impact expected.
| Photo Credit:
PRASHANTH VISHWANATHAN

Aurobindo Pharma Limited reported a fire incident at its subsidiary Lyfius Pharma Private Limited’s Penicillin-G manufacturing facility in Kakinada SEZ, Andhra Pradesh. The incident occurred at approximately 10 PM on April 27, 2025, near the coal crusher area, the company announced on Monday.

No injuries were reported in the incident, which damaged ancillary equipment but spared core manufacturing infrastructure. As a precautionary measure, operations at the plant will be suspended for an estimated 20 to 25 days while equipment is replaced.

The company stated that the facility is fully insured, and the damage is currently under evaluation. The fire reportedly resulted from self-ignition of coal, though the exact cause is still being investigated.

“The incident is not expected to have material impact on the operations or financials of the group,” Aurobindo Pharma assured investors. The pharmaceutical manufacturer remains committed to resuming operations while maintaining safety and quality standards.

Lyfius Pharma Private Limited is a wholly owned stepdown subsidiary of Aurobindo Pharma.

The shares of Aurobindo Pharma Limited were trading at ₹1,205.10 down by ₹42.10 or 3.38 per cent on the NSE today at 10.20 am.

Published on April 29, 2025